Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,051,347
-$20,238,948 QoQ
Shares Held
4,866
-95.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#445
of 1,036 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Jun 30, 2026CallValue
$84,047,340
CallShares
389,000
PutValue
$62,268,492
PutShares
288,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. BIIB ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in BIIB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,047,340 | 389,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,051,347 | 4,866 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $62,268,492 | 288,200 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $21,290,295 | 116,131 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $28,287,819 | 154,300 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $1,518,793 | 8,630 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $2,162,345 | 15,802 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,217,340 | 14,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,574,174 | 8,121 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,497,557 | 6,460 | Shares | Other | 2024-08-14 | |
| 2023-09-30 | $23,773,425 | 92,500 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $3,930,710 | 15,294 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $18,710,328 | 72,800 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $49,940,186 | 175,321 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $65,173,680 | 228,800 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $7,121,250 | 25,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $9,854,217 | 35,443 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $182,975,100 | 685,300 | Call | Sole | 2022-11-14 | |
| 2021-12-31 | $5,609,569 | 23,381 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,715,266 | 20,196 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,897,033 | 22,806 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,662,207 | 13,091 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,582,164 | 67,721 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||